alginate--aluminium-hydroxide--magnesium-trisilicate--sodium-bicarbonate-drug-combination and Overweight

Gastroesophageal reflux disease is a highly frequent disorder classically characterized by the presence of heartburn and/or acid regurgitation that improves with drug therapy that reduces acid content in the stomach. However, especially in patients with non-erosive disease, response to proton pump inhibitors is unsatisfactory in approximately 1 out of 3 patients, and consequently, in these patients, it is important to establish a definitive diagnosis and an alternative therapeutic strategy. In the last few years, advances have been made in knowledge of the physiopathology of reflux, such as identification of the role of the acid pocket in producing reflux, technological advances that allow differentiation among acid reflux, non-acid reflux and slightly acid reflux, and advances in the treatment of reflux with drugs that attempt to act on the barrier function of the esophagogastric junction.

Topics: Alginates; Aluminum Hydroxide; Antacids; Comorbidity; Drug Combinations; Electric Impedance; Esophageal pH Monitoring; Esophagogastric Junction; Fundoplication; Gastric Emptying; Gastroesophageal Reflux; Gastroscopy; Hernia, Hiatal; Humans; Manometry; Overweight; Postprandial Period; Posture; Prevalence; Proton Pump Inhibitors; Silicic Acid; Sodium Bicarbonate